Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Revealing the neuroimmune communication for better treatment outcomes in food allergy

Project description

Neuroimmune control of food allergy and immunotherapy response

The treatment for food allergies is based on prevention and intervention. Oral immunotherapy often fails to provide lasting protection. Supported by the Marie Skłodowska-Curie Actions programme, the AllergyREBELL project explores the role of gut nerve cells in regulating immune responses. By using advanced imaging and spatial multi-omics in murine models, the project maps the complex communication between the nervous and immune systems in the small intestine. This research into how neural signals influence immune cell behaviour aims to shed light on why immunotherapies succeed or fail. Overall, the project seeks to translate these insights into safer, more effective therapeutic strategies.

Objective

Current management of potentially life-threatening food allergy (FA) relies on strict food avoidance and emergency medications such as ephedrine auto-injectors for acute reactions. Although oral allergen immunotherapy (OIT), gradual updosing of the offending food, has shown great promise in inducing oral tolerance, these effects are often transient and patients with severe initial symptoms are frequently non-responders. Thus, there is a pressing need for improved OIT protocols. Neuro-immune dialogue shapes the immune response in allergic asthma: activation of lung-innervating sensory neurons (nociceptors) by allergen exposure amplifies allergic lung inflammation. Comparably, gut-innervating nociceptors can also be activated through allergen exposure, pointing toward a similar neuro-immune dialogue in FA. It is currently unclear how nociceptors communicate with immune cells in FA and how this communication influences OIT outcome. In AllergyREBELL, I will identify crucial neuroimmune circuits for FA maintenance and tolerance induction by (1) constructing neuroimmune communication maps in the small intestine using a murine FA mouse model in combination with spatial transcriptomics, spatial lipidomics coupled to proteomics and intravital microscopy to track immune cell movements, (2) determining the modulatory capacity of neural factors using a sophisticated immune cell co-culture model and (3) characterising activation profiles of allergy-relevant nociceptors upon allergen exposure. This project will provide a multi-omics atlas on neuroimmune communication in FA as well as first insights how this communication modulates immune responses critical for tolerance induction. My paramount goal with AllergyREBELL is to identify crucial neuroimmune axes, which can be potentially exploited as therapeutic add-ons to improve OIT for non-responding patients and thus, increasing patients’ quality of life by reducing their constant fear of accidental exposures.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

KAROLINSKA INSTITUTET
Net EU contribution
€ 252 180,00
Address
NOBELS VAG 5
171 77 STOCKHOLM
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)